Evidence map›Paper›PMID 34326314›Full record

ArticleCell death & disease2021

EGR2-mediated regulation of m

Yufan Ying, Xueyou Ma, Jiajie Fang, Shiming Chen, Weiyu Wang, Jiangfeng Li, Haiyun Xie, Jian Wu, Bo Xie, Ben Liu and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. mFrontiers in cell and developmental biology · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Yufan YingDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Xueyou MaDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Jiajie FangDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Shiming ChenDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Weiyu WangDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Jiangfeng LiDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Haiyun XieDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Jian WuDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Bo XieDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Ben LiuDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China.
Xiao WangDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China. zjuwangxiao@zju.edu.cn.
Xiangyi ZhengDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China. zheng_xy@zju.edu.cn.
Liping XieDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, 310000, Hangzhou, Zhejiang, China. xielp@zju.edu.cn.
Zhejiang University · CN

Funding

China Postdoctoral Science Foundation 2020M681885National Natural Science Foundation of China (National Science Foundation of China) 81772744National Natural Science Foundation of China (National Science Foundation of China) 81802564National Natural Science Foundation of China (National Science Foundation of China) 81874203National Natural Science Foundation of China (National Science Foundation of China) 81972374National Natural Science Foundation of China (National Science Foundation of China) 82072848Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LQ21H160030Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LY20H160022
6 · The paper itself

Abstract

Emerging discoveries of dynamic and reversible N6-methyladenosine (m

Indexed as

AdenosineAdultAgedCarcinogenesisCarcinoma, Renal CellCell Cycle ProteinsCell Line, TumorCell MovementCell ProliferationEarly Growth Response Protein 2FemaleGene Expression Regulation, NeoplasticHumansKidney NeoplasmsMaleMiddle AgedAdenosineCell Cycle ProteinsEarly Growth Response Protein 2EGR2 protein, humanIGF2BP1 protein, humanN-methyladenosineRNA-Binding ProteinsRNA, MessengerRNA Splicing Factorssphingosine-1-phosphate receptor-3, humanSphingosine-1-Phosphate ReceptorsWTAP protein, human

Identifiers

PMID34326314
PMCPMC8322060
OpenAlexW3185198219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.